ALK GENE MUTATION
Clinical trials for ALK GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new ALK GENE MUTATION trials appear
Sign up with your email to follow new studies for ALK GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for ALK lung cancer patients
Disease control OngoingThis study tests two treatment options for people with advanced ALK-positive non-small cell lung cancer who have not had treatment yet. One group gets the targeted drug brigatinib alone, and the other gets brigatinib plus chemotherapy. The goal is to see if the combination helps …
Matched conditions: ALK GENE MUTATION
Phase: PHASE2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Smartphone app and fitbit join forces to monitor lung cancer treatment side effects
Knowledge-focused OngoingThis study involves 30 lung cancer patients taking oral targeted therapy. They will use a smartphone app, a Fitbit, and a smart pill cap to track symptoms and medication use for up to 24 weeks. The goal is to see if this remote monitoring system is practical and can help improve …
Matched conditions: ALK GENE MUTATION
Phase: NA • Sponsor: University of Virginia • Aim: Knowledge-focused
Last updated May 18, 2026 12:03 UTC